Stablecoin Development Corporation (SDEV), a Nasdaq-listed company that previously operated under the name NovaBay Pharmaceuticals, has executed a dramatic pivot from healthcare to cryptocurrency by investing over $100 million in SKY tokens. The move underscores a growing trend of traditional enterprises entering the digital asset space.
From Pharmaceuticals to Crypto
SDEV raised approximately $134 million in a private financing round, with participation from venture capital firm Framework Ventures and stablecoin issuer Tether Investments. This capital was used to acquire a massive position in SKY tokens, marking the company's full commitment to the crypto ecosystem. The transition reflects a strategic shift away from its original healthcare business.
$100M Bet on SKY Token
According to regulatory filings, SDEV now holds about 2.06 billion SKY tokens, valued at roughly $147 million. This represents 8.78% of SKY's total circulating supply. The tokens were acquired via secondary market purchases and as part of financing considerations. SKY's price rose 1.19% in the last 24 hours, trading against USDT with minimal volatility.
Staking Rewards and Long-Term Strategy
SDEV has already begun staking its SKY holdings, earning 26.6 million SKY in rewards to date. This approach generates passive income and grants the company governance rights within the SKY network. Market observers note that such large-scale staking reduces available supply, which could support higher token prices over the long term.
Institutional Confidence and Market Implications
The involvement of Framework Ventures and Tether highlights strong institutional confidence in SKY's ecosystem. SDEV's move mirrors similar cross-sector pivots by companies like MicroStrategy, which have embraced Bitcoin. As more traditional firms allocate capital to crypto, SKY's holder base is expected to diversify, potentially reducing price volatility while increasing liquidity depth.